Pharmaceutical Company Recalls Panic Disorder Drug Over Mislabeling: FDA

A batch of clonazepam disintegrating tablets made by Endo USA has erroneous strength labeling that could lead to overdoses, according to an FDA announcement

The U.S. Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Endo USA Inc. said it’s recalling one lot of clonazepam disintegrating tablets because of mislabeled strength information. The company is warning consumers not to take the drug, according to a notice published by the U.S. Food and Drug Administration (FDA) last week.

Clonazepam, which is sometimes marketed as Klonopin, is a benzodiazepine drug that’s approved by the FDA to treat anxiety, epilepsy, and panic disorders. Off-label, the drug can be prescribed for restless leg syndrome, insomnia, and acute mania.